Mechanisms of cardio-renal protection of sodium-glucose cotransporter-2 inhibitors

被引：10

作者：

Chiriaco, Martina ^{[1
]}

Trico, Domenico ^{[1
]}

Solini, Anna ^{[2
]}

机构：

[1] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy

[2] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy

来源：

CURRENT OPINION IN PHARMACOLOGY | 2022年 / 66卷

关键词：

HEART-FAILURE; SGLT2; INHIBITORS; KIDNEY; OUTCOMES; DISEASE;

D O I：

10.1016/j.coph.2022.102272

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are glucose-lowering drugs used in the treatment of type 2 diabetes (T2D) that have shown additional cardiac and renal benefits. The mechanisms of SGLT2i-mediated cardiorenal protection include blood pressure lowering and endothelial function improvements, enhancement of cardiac and renal hemodynamics, optimization of energetic efficiency through metabolic changes and cellular ion exchanges, reduction of inflammation and oxidative stress with consequent fibrosis reduction, and sympathetic activity modulation. This review explores the most recent data regarding the physiological mechanisms of SGLT2i cardiac and renal benefits, which lie at the root of the solid clinical evidence on cardiorenal protection, making SGLT2i a promising new pharmacological approach to the treatment of patients at high risk of cardiorenal syndrome.

引用

页数：7

共 55 条

[31] The importance of endothelial dysfunction in resistance artery remodelling and cardiovascular risk [J].

Masi, Stefano ;

Georgiopoulos, Georgios ;

Chiriaco, Martina ;

Grassi, Guido ;

Seravalle, Gino ;

Savoia, Carmine ;

Volpe, Massimo ;

Taddei, Stefano ;

Rizzoni, Damiano ;

Virdis, Agostino .

CARDIOVASCULAR RESEARCH, 2020, 116 (02) :429-437

[32] Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis [J].

Masson, Walter ;

Lavalle-Cobo, Augusto ;

Patricio Nogueira, Juan .

CELLS, 2021, 10 (08)

[33] Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis [J].

McGuire, Darren K. ;

Shih, Weichung J. ;

Cosentino, Francesco ;

Charbonnel, Bernard ;

Cherney, David Z. I. ;

Dagogo-Jack, Samuel ;

Pratley, Richard ;

Greenberg, Michelle ;

Wang, Shuai ;

Huyck, Susan ;

Gantz, Ira ;

Terra, Steven G. ;

Masiukiewicz, Urszula ;

Cannon, Christopher P. .

JAMA CARDIOLOGY, 2021, 6 (02) :148-158

[34] Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure The RECEDE-CHF Trial [J].

Mordi, Natalie A. ;

Mordi, Ify R. ;

Singh, Jagdeep S. ;

McCrimmon, Rory J. ;

Struthers, Allan D. ;

Lang, Chim C. .

CIRCULATION, 2020, 142 (18) :1713-1724

[35] Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients [J].

Nielsen, Roni ;

Moller, Niels ;

Gormsen, Lars C. ;

Tolbod, Lars Poulsen ;

Hansson, Nils Henrik ;

Sorensen, Jens ;

Harms, Hendrik Johannes ;

Frokiaer, Jorgen ;

Eiskjaer, Hans ;

Jespersen, Nichlas Riise ;

Mellemkjaer, Soren ;

Lassen, Thomas Ravn ;

Pryds, Kasper ;

Botker, Hans Erik ;

Wiggers, Henrik .

CIRCULATION, 2019, 139 (18) :2129-2141

[36] Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure [J].

Packer, Milton ;

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Pocock, Stuart J. ;

Carson, Peter ;

Januzzi, James ;

Verma, Subodh ;

Tsutsui, Hiroyuki ;

Brueckmann, Martina ;

Jamal, Waheed ;

Kimura, Karen ;

Schnee, Janet ;

Zeller, Cordula ;

Cotton, Daniel ;

Bocchi, Edimar ;

Boehm, Michael ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure, Eduardo ;

Giannetti, Nadia ;

Janssens, Stefan ;

Zhang, Jian ;

Juanatey, Jose R. Gonzalez ;

Kaul, Sanjay ;

Brunner-La Rocca, Hans-Peter ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio ;

Pina, Ileana ;

Ponikowski, Piotr ;

Sattar, Naveed ;

Senni, Michele ;

Seronde, Marie-France ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Wanner, Christoph ;

Zannad, Faiez .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1413-1424

[37] Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials [J].

Palmer, Suetonia C. ;

Tendal, Britta ;

Mustafa, Reem A. ;

Vandvik, Per Olav ;

Li, Sheyu ;

Hao, Qiukui ;

Tunnicliffe, David ;

Ruospo, Marinella ;

Natale, Patrizia ;

Saglimbene, Valeria ;

Nicolucci, Antonio ;

Johnson, David W. ;

Tonelli, Marcello ;

Rossi, Maria Chiara ;

Badve, Sunil, V ;

Cho, Yeoungjee ;

Nadeau-Fredette, Annie-Claire ;

Burke, Michael ;

Faruque, Labib, I ;

Lloyd, Anita ;

Ahmad, Nasreen ;

Liu, Yuanchen ;

Tiv, Sophanny ;

Millard, Tanya ;

Gagliardi, Lucia ;

Kolanu, Nithin ;

Barmanray, Rahul D. ;

McMorrow, Rita ;

Cortez, Ana Karina Raygoza ;

White, Heath ;

Chen, Xiangyang ;

Zhou, Xu ;

Liu, Jiali ;

Rodriguez, Andrea Flores ;

Gonzalez-Colmenero, Alejandro Diaz ;

Wang, Yang ;

Li, Ling ;

Sutanto, Surya ;

Solis, Ricardo Cesar ;

Gonzalez-Colmenero, Fernando Diaz ;

Rodriguez-Gutierrez, Rene ;

Walsh, Michael ;

Guyatt, Gordon ;

Strippoli, Giovanni F. M. .

BMJ-BRITISH MEDICAL JOURNAL, 2021, 372

[38] Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study [J].

Penno, Giuseppe ;

Orsi, Emanuela ;

Solini, Anna ;

Bonora, Enzo ;

Fondelli, Cecilia ;

Trevisan, Roberto ;

Vedovato, Monica ;

Cavalot, Franco ;

Gruden, Gabriella ;

Laviola, Luigi ;

Nicolucci, Antonio ;

Pugliese, Giuseppe .

BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)

[39] Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin [J].

Philippaert, Koenraad ;

Kalyaanamoorthy, Subha ;

Fatehi, Mohammad ;

Long, Wentong ;

Soni, Shubham ;

Byrne, Nikole J. ;

Barr, Amy ;

Singh, Jyoti ;

Wong, Jordan ;

Palechuk, Taylor ;

Schneider, Chloe ;

Darwesh, Ahmed M. ;

Maayah, Zaid H. ;

Seubert, John M. ;

Barakat, Khaled ;

Dyck, Jason R. B. ;

Light, Peter E. .

CIRCULATION, 2021, 143 (22) :2188-2204

[40] Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure [J].

Pietschner, R. ;

Kolwelter, J. ;

Bosch, A. ;

Striepe, K. ;

Jung, S. ;

Kannenkeril, D. ;

Ott, C. ;

Schiffer, M. ;

Achenbach, S. ;

Schmieder, R. E. .

CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)

← 1 2 3 4 5 6 →